Pharmacy Conference: General CE – Pharmacist
(5 hrs. CPE)

Pharmacy Conference: General CE – Pharmacist
(5 hrs. CPE)


ACCREDITATION i CARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE application-based* and knowledge-based activity. Participants may receive up to 5 hours of CPE credit by attending sessions and successfully completing the CPE activity evaluation.  

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.  

DISCLOSURES Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.  

TARGET AUDIENCE Pharmacists of all practice backgrounds

CANCELLATION POLICY Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

ZOOM WEBINAR INFORMATIONParticipants may join via any electronic device. Be sure to have downloaded the ZOOM software in advance to avoid any delays. You will be able to see the speakers and their presentations. You will be able to respond to speaker learning assessments via the CHAT Feature and ask questions via the Q&A Feature.




Validation and Counseling of Prescriptions for Controlled Substance and Opioids


Joseph Cammilleri, PharmD, BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain/Palliative Care Program Director, UF Health.  

Upon completion of this activity, pharmacists will be able to: Describe how to ensure access to controlled substances for all patients with a valid prescription; Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate therapeutic value; Detect prescriptions that are not based on a legitimate medical purpose; Discuss the laws and rules related to the prescribing and dispensing of controlled substances; Discuss proper patient storage and disposal of controlled substances; Discuss protocols for addressing and resolving problems recognized during the drug utilization review; Provide education on section 381.887, F.S., emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone; Counsel patients with opioid prescriptions; Provide available treatment resources for opioid physical dependence, addiction, misuse, or abuse.

UAN: 0675-0000-24-018-L08-P*  

Management of HIV AIDS                                                     


Briana Journee, PharmD, MBA, CPh, AAHIVP, Medical Science Liaison, ViiV Healthcare

Upon completion of this activity, pharmacists will be able to: Identify current modes of transmission of HIV and prevention strategies; Describe the epidemiology of HIV and the importance of infection control procedures; Distinguish the various therapeutic agents used to treat HIV AIDS; List complications associated with HIV/AIDS; State Florida law on HIV/AIDS and its impact on testing, reporting, confidentiality, procedures for pregnant women and partner notification; Identify the pharmacist role in providing care for HIV infected patients.

UAN: 0675-0000-24-019-L02-P

Mitigation and Prevention of Medication Errors in Pharmacy Practice


Norman P. Tomaka, BS Pharm, MS, CPh, FAPhA, Clinical Consultant Pharmacist, Consultant Pharmacy Services

Upon completion of this activity, pharmacists will be able to:  Recognize statutory responsibilities that foster ongoing pharmacy regulatory compliance; Recognize recurring medication errors; Describe quality improvement regulations for pharmacies licensed in Florida; Define elements of a proactive Continuous Quality Improvement process that promotes ongoing quality; Discuss the use of Root Cause Analysis (RCA) to enhance quality pharmacy services and prevent errors; Describe the implementation of an action plan to improve overall pharmacy practice quality and mitigate medication errors; Demonstrate enactment of procedures that promote ongoing patient safety in pharmacy practice.

UAN: 0675-0000-24-020-L05-P